# Effect of Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing Allo-HSCT

> **NCT02850822** · — · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 250 (estimated)

## Conditions studied

- Myelodysplastic Syndrome
- Chemotherapy

## Interventions

- **DRUG:** Demethylation drug
- **DRUG:** Chemotherapy regimen

## Key facts

- **NCT ID:** NCT02850822
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2019-06
- **Final completion:** 2020-06
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2017-12-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02850822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02850822, "Effect of Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing Allo-HSCT". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02850822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*